Association of Helicobacter pylori Infection with Respiratory Diseases in Cameroon Patients, Using GastroPanel® Serological Biomarkers (Pepsinogen I; Pepsinogen II; Gastrin-17; Helicobacter pylori IgG)

Introduction: Helicobacter pylori (H. pylori) is a microaerophilic gram-negative bacterium that colonizes the gastric mucosa and provokes inflammation and immune responses throughout life with liberation of diversecytotoxique substances dependent on host. Infection to H. pylori has been associated to a number of respiratory complications, including chronic obstructive pulmonary dieases, bronchectasis, asthma, tuberculosis and lung cancer. Epidemiological data on the association of H. pylori infection respiratory diseases are rare in Cameroon. We sought to evaluate the prevalence H. pylori infection among patient with respiratory diseases.

Methodology: Blood samples were aseptically collected for the measurements Helicobacter pylori IgG antibodies, pepsinogene I et II levels, gastrine-17. The blood samples required for the study were collected prospectively. Ethical clairance was obtained from the Centre Regional Ethics Committee for Human Sciences. An authorization of research was obtained from the authorities of Jamot Hospital of Yaounde. All participants signed an informed consent form.

Results: The GastroPanel® results showed that the prevalence of H. pylori infection was 42(46.67%). We observed an H. pylori seroprevalence of 75%, 41.9%, 50.0% and 33,33% amongst sujects with bronchitis, Tuberculosis, Asthma and pneumonia respectively.